Deals•Feb 20, 2026
AlayaCare Secures $50M Growth Capital Facility From CIBC Innovation Banking
AlayaCare Inc., a Montreal‑based provider of home and community care software, secured a $50 million growth‑capital facility from CIBC Innovation Banking. The funding will fuel the company's expansion and support strategic mergers and acquisitions. The partnership builds on a relationship dating back to 2014.
FinSMEs
Deals•Feb 20, 2026
Novartis to Sell 70.68% Stake in Novartis India to Consortium for ₹1,446 Crore
Novartis AG announced the sale of its 70.68% stake in Novartis India Ltd. to a consortium of WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners for ₹1,446 crore. The share purchase agreement was signed on 19 February 2026, concluding...
The Hindu BusinessLine — Economy/Markets
Deals•Feb 20, 2026
Axis Medical Secures Undisclosed Investment From Spur Ridge Capital
Denver-based Axis Medical, a distributor of spinal implant and orthobiologic technologies, received an undisclosed investment from Spur Ridge Capital. The funding will be used to accelerate growth through operational infrastructure, sales initiatives, and strategic expansion, including acquisitions, while the company...
FinSMEs
Deals•Feb 19, 2026
Braidwell Invests $45M in BrightSpring, Shares Jump 86%
Private equity firm Braidwell Capital has taken a $45 million equity stake in BrightSpring, a provider of healthcare services. The investment, announced on Feb. 19, 2026, sent BrightSpring's stock up 86% in after‑hours trading.
Motley Fool Investing
Deals•Feb 19, 2026
Flinn Raises $20M to Develop AI-Driven Product Lifecycle Tools for Medtech and Pharma
Flinn announced a $20 million fundraising round to accelerate development of artificial intelligence tools for product lifecycle management in the medtech and pharmaceutical sectors. The capital will be used to build AI-driven solutions that streamline design, compliance, and market launch...
Tech.eu
Deals•Feb 19, 2026
Altesa BioSciences Secures $75M Series B Funding
Altesa BioSciences announced a $75 million Series B financing round, bolstering its pipeline in the biotech sector. The new capital will support the company's research and development initiatives and accelerate growth.
FinSMEs
Deals•Feb 19, 2026
Hims & Hers to Acquire Eucalyptus in $1.15B Deal
Direct-to-consumer virtual care company Hims & Hers announced it has signed an agreement to acquire international digital health platform Eucalyptus for up to $1.15 billion. The transaction includes $240 million cash at closing and the remainder in deferred and earn‑out payments, with...
MobiHealthNews (HIMSS Media)
Deals•Feb 19, 2026
Warburg Pincus in Final Talks to Acquire Integrace Health for ₹1,200 Crore
US private‑equity firm Warburg Pincus is in advanced talks to acquire Mumbai‑based formulations maker Integrace Health for about ₹1,200 crore. Integrace, currently owned by True North Fund VI LLP and Temasek’s V‑Science Investments, is expected to sign the deal in a...
ETCFO – Corporate Finance
Deals•Feb 18, 2026
Unnatural Products Secures $1.8B Cardio Pact with Novartis
Biotech firm Unnatural Products announced a $1.8 billion partnership with pharmaceutical giant Novartis to develop cardiovascular therapies. The agreement includes a corporate investment from Novartis, marking a significant funding boost for Unnatural Products.
BioWorld (Citeline) – Featured Feeds
Deals•Feb 18, 2026
Arsenal Sells MaxHealth to CenterWell in Private Equity Acquisition
Arsenal, a private equity firm, has sold its portfolio company MaxHealth to CenterWell, a healthcare provider, in a strategic acquisition. The deal expands CenterWell's service offerings and marks a notable transaction in the healthcare private equity space.
JD Supra (Labor & Employment)
Deals•Feb 18, 2026
IBM Ventures Invests in SQK and QodeX Quantum for Specialized Software Development
IBM Ventures announced new investments in early‑stage quantum software startups SQK and QodeX Quantum, supporting SQK's hybrid quantum‑classical algorithms for medical imaging and QodeX's quantum‑native AI platform. The undisclosed funding aims to accelerate the quantum software ecosystem and give the...
Quantum Computing Report
Deals•Feb 18, 2026
Tencent Acquires 35% Stake in Insighta From Prenetics for $70M
Prenetics Global Limited announced the sale of its 35% equity stake in Insighta to Tencent for $70 million in cash, as part of its strategic transformation to focus on its IM8 health brand. The deal, reported on February 18 2026, provides Prenetics with...
GlobeNewswire – Earnings Releases
Deals•Feb 18, 2026
Cencora to Acquire Covetrus in $3.5B Animal Health Merger
Cencora announced a $3.5 billion merger with Covetrus, creating a leading animal health company. The transaction, guided by three advisory firms, combines Cencora's distribution capabilities with Covetrus's veterinary services platform. The deal is expected to close later this year.
Law360 — Mergers & Acquisitions
Deals•Feb 18, 2026
Synchrony Medical Raises $5M to Commercialize LibAirty Airway Clearance System
Synchrony Medical announced a $5 million fundraising round to fund the commercialization of its LibAirty airway clearance system. The capital will be used to scale production, pursue regulatory approvals, and expand market reach. The round marks a significant step in...
HIT Consultant
Deals•Feb 18, 2026
Gilead to Acquire Genhouse in $1.5B+ Deal to Accelerate Synthetic Lethality
Gilead Sciences announced a deal to acquire Genhouse for over $1.5 billion, aiming to strengthen its synthetic lethality oncology pipeline. The acquisition brings Genhouse’s portfolio of synthetic lethality drug candidates and technology into Gilead’s pipeline, underscoring its commitment to precision oncology.
BioWorld (Citeline) – Featured Feeds